---
document_datetime: 2025-01-07 14:17:42
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/fampridine-accord-epar-all-authorised-presentations_en.pdf
document_name: fampridine-accord-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8613272
conversion_datetime: 2025-12-18 23:50:26.86192
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form      | Route of Administration   | Immediate Packaging   | Pack size                                    |
|------------------|-------------------|------------|--------------------------|---------------------------|-----------------------|----------------------------------------------|
| EU/1/20/1477/001 | Fampridine Accord | 10 mg      | Prolonged-release tablet | Oral use                  | blister (alu/alu)     | 28 x 1 tablets (unit dose)                   |
| EU/1/20/1477/002 | Fampridine Accord | 10 mg      | Prolonged-release tablet | Oral use                  | blister (alu/alu)     | 56 x 1 tablets (unit dose)                   |
| EU/1/20/1477/003 | Fampridine Accord | 10 mg      | Prolonged-release tablet | Oral use                  | blister (alu/alu)     | 49 x 1 tablets (unit dose)                   |
| EU/1/20/1477/004 | Fampridine Accord | 10 mg      | Prolonged-release tablet | Oral use                  | blister (alu/alu)     | 196 (4x49x1) tablets (unit dose) (multipack) |